Prespecified adverse clinical outcomes in the CMR substudy participants
| Characteristic | Culprit-artery-only PCI n=42 (50%) | Preventive PCI n=42 (50%) |
|---|---|---|
| Primary outcome* | ||
| Death from cardiac causes, non-fatal myocardial infarction or refractory angina | 7 | 4 |
| Death from cardiac causes or non-fatal myocardial infarction | 4 | 2 |
| Death from cardiac causes | 2 | 0 |
| Non-fatal myocardial infarction | 2 | 2 |
| Refractory angina | 3 | 2 |
| Secondary outcomes* | ||
| Death from non-cardiac causes | 2 | 2 |
| Repeat revascularisation | 4 | 3 |
In line with the preventive angioplasty in myocardial infarction (PRAMI) protocol11 the study participants underwent standard care follow-up led by the attending physician. Routine stress testing was not performed and instead stress tests and repeat revascularisation during follow-up were clinically indicated based on a history of angina in line with contemporary guidelines.
*The follow-up interval is from randomisation to 1 December 2015.
CMR, cardiac magnetic resonance; PCI, percutaneous coronary intervention.